Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Eurofins says independent audit refutes short seller's allegations

Oct 22 (Reuters) - French laboratory testing company
Eurofins Scientific  EUFI.PA  said on Tuesday an independent
audit by Ernst & Young Paris had found no material misstatements
in its cash statements, refuting earlier allegations by short
seller Muddy Waters.
    
    WHY IT'S IMPORTANT
    On June 24, the Eurofins shares fell more than 16% after
Muddy Waters questioned its financial statements and specific
real estate transactions in a report. Eurofins denied the
allegations at the time.
    The shares have regained their losses since then, and the
results from the audit could help further stabilize Eurofins'
market position.
    
    BY THE NUMBERS
    The audit identified two individual exceptions of above
100,000 euros ($108,220), resulting in an overstatement of 1.2
million euros, but those were considered immaterial and had been
corrected in Eurofins' half-year 2024 statement.
    The company also slightly trimmed its revenue guidance for
the full year on Tuesday, expecting it to be close to 7 billion
euros versus the previous forecast of between 7.075 billion and
7.175 billion euros.

($1 = 0.9240 euros)

 (Reporting by Leo Marchandon in Gdansk; editing by Milla Nissi)
 ((Leo.Marchandon@thomsonreuters.com;))

Recent news on Eurofins Scientific SE

See all news